|Bid||0.00 x 800|
|Ask||0.00 x 900|
|Day's range||159.60 - 162.48|
|52-week range||132.24 - 243.52|
|Beta (5Y monthly)||0.55|
|PE ratio (TTM)||26.27|
|Earnings date||24 Jan 2024 - 29 Jan 2024|
|Forward dividend & yield||1.92 (1.19%)|
|Ex-dividend date||08 Nov 2023|
|1y target est||178.38|
Envista (NVST) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
ResMed Inc (NYSE:RMD), a global leader in the development, manufacturing, and marketing of innovative medical products for the treatment and management of respiratory disorders, with a focus on sleep-disordered breathing, has recently witnessed a significant insider sell by its Chief Financial Officer (CFO), Brett Sandercock.